Nutrient intake and stimulant drugs in hyperactive children.
Recent studies have demonstrated suppressed growth of height and weight in children receiving stimulant drugs for hyperactivity. For approximately twelve months, growth data and food records were collected on two subjects receiving different types and dosages of stimulant drugs. The two cases demonstrated that dextroamphetamine levels of 10 mg. or more and methylphenidate levels of 30 mg. or more decreased caloric intake significantly. This decrease may be limiting for long-term growth. Both subjects had a variety of feeding problems due to poor appetite. Careful nutritional evaluation and planning are important to insure optimal energy and nutrient intake in these children receiving stimulant drugs.
D001205:Ascorbic Acid; D002136:Calcium, Dietary; D002648:Child; D002986:Clinical Trials as Topic; D003913:Dextroamphetamine / Q000494:pharmacology* / Q000627:therapeutic use; D004032:Diet / Q000592:standards; D004044:Dietary Proteins; D004305:Dose-Response Relationship, Drug; D002149:Energy Intake; D001068:Feeding and Eating Disorders; D006128:Growth / Q000187:drug effects*; D006801:Humans; D006948:Hyperkinesis / Q000188:drug therapy; D007501:Iron; D008297:Male; D008774:Methylphenidate / Q000494:pharmacology* / Q000627:therapeutic use; D014801:Vitamin A
D002136:Calcium, Dietary; D004044:Dietary Proteins; D014801:Vitamin A; D008774:Methylphenidate; D007501:Iron; D001205:Ascorbic Acid; D003913:Dextroamphetamine